LINDSEY COLLINS: Open Payments
NPI 1033782735 · ELKTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 16 payments from 5 companies in 2025. Trend: 2023 $253 · 2024 $419 · 2025 $462
Food & beverage: $277Education: $185
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 11 | $347 |
| Sage Therapeutics, LLC | 2 | $43 |
| Organon LLC | 1 | $30 |
| Exeltis, USA Inc. | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
Products named: Veozah, ZURZUVAE, NEXPLANON, SLYND, Qelbree.
Industry payments across MD — which companies pay providers there.
